Also, in an unbiased drug screen of epigenetic regulators in mouse-derived endometrial cancer organoids, menin inhibitors MI-136 and MI-463 were found to significantly reduce organoid growth in vitro [303]. Here, MEN1 is linked to endometrial cancer.